of enantiomerically pure sulfinamides are rather limited. We
disclosed previously a general process for rapid access to a
variety of aryl or alkyl sulfinamides in optically pure form
with equal accessibility to either enantiomer. Included in this
list of examples is tert-butanesulfinamide prepared from
optically pure N-sulfonyl [1,2,3]-oxathiazolidine-2-oxide and
its application for the syntheses of several drug candidates.3
Recently, we reported another efficient asymmetric synthesis
of enantiopure sulfinates, which are common precursors to
access both sulfoxides and sulfinamides.4 High diastereo-
selectivity for the addition of nucleophiles such as Grignards,
lithium reagents, or enolates to sulfinimines has been
demonstrated, and a chelated cyclic transition state has been
proposed for the high selectivity observed in this process.5
However, the concept of obtaining a reversal of diastereo-
selectivity while utilizing the same enantiomer of either (R)-
or (S)-sulfinimines by altering the transition state has not
yet been well documented for these reaction systems (Scheme
1).6
Scheme 2. Retrosynthetic Analysis for Preparation of the
Hydroxyl Derivatives of Sibutramine
uptake inhibitors that can be potentially used for the treatment
of CNS disorders.7 To identify the absolute configuration
of the active metabolite, as well as conduct a comparison of
the biological activities of these stereoisomers, efficient
synthetic methods were needed to prepare the stereoisomers.
Herein, we report the first efficient stereoselective syntheses
of all four isomers of 1-OH-DDMS using (R)-tert-butane-
sulfinamide-derived sulfinimine intermediate (1) as the
common synthon for preparation of each stereoisomer. In
this case, we demonstrated the above concept to manipulate
the diastereoselectivity by taking advantage of solvent effects.
The synthesis starts with the preparation of a common
single enantiomer of the key intermediate, the (R)-tert-
butanesulfinyl imine 1. Condensation of the aldehyde 2 with
(R)-tert-butylsulfinamide in THF at 22 °C, catalyzed by
Ti(OEt)4, gave 1 in 94% yield (Scheme 3). Next, addition
Scheme 1. Mechanistic Models to Predict the Stereochemical
Outcomes of the Nucleophilic Additions
Scheme 3. Diastereoselective Addition of Lithium Reagent
(R)-3 to (R)-t-Butanesulfinimide 1
As part of our program to develop improved chemical
entities (ICEs) from important existing drugs, we were
interested in investigating each of the potential metabolites
of the antiobesity drug sibutramine (Scheme 2). Preliminary
preclinical studies indicated that the hydroxylated derivatives
of sibutramine (1-OH-DDMS) are potent monoamine re-
(1) (a) Johansson, A. Contemp. Org. Synth. 1995, 2, 393. (b) Enders,
D.; Reinhold, U. Tetrahedron: Asymmetry 1997, 8, 1895. (c) Bloch, R.
Chem. ReV. 1998, 98, 1407. (d) Kobayashi, S.; Ishitani. H. Chem. ReV.
1999, 99, 1069. (e) Senanayake, C. H.; Krishnamurthy, D. Curr. Opin. Drug
DiscoVery DeV. 1999, 2, 590.
(2) For recent reviews, see: (a) Ellman, J.; Owens, T. D.; Tang, T. P.
Acc. Chem. Res. 2002, 35, 984. (b) Ellman, J. A. Pure Appl. Chem. 2003,
75, 39. (c) Zhou, P.; Chen, B.-C.; Davis, F. A. Tetrahedron 2004, 60, 8003.
(3) (a) Han, Z.; Krishnamurthy, D.; Grover, P.; Fang, Q. K.; Senanayake,
C. H. J. Am. Chem. Soc. 2002, 124, 7880. (b) Pflum, D. A.; Krishnamurthy,
D.; Han, Z.; Wald, S. A.; Senanyake, C. H. Tetrahedron Lett. 2002, 43,
923. (c) Han, Z.; Krishnamurthy, D.; Pflum, D. A.; Grover, P.; Wald, S.
A.; Senanyake, C. H. Org. Lett. 2002, 4, 4025.
(4) Lu, B. Z.; Jin, F.; Zhang, Y.; Wu X.; Wald, S. A.; Senanayake, C.
H. Org. Lett. 2005, 7, 1465.
(5) Cogan, D. A.; Liu, G. C.; Ellman, J. Tetrahedron 1999, 55, 8883.
(6) Reversal in the diastereoselectivity was observed for addition of
arylmetal species to sulfinimines derived from aromatic aldehydes. Plobeck,
N.; Powell, D. Tetrahedron: Asymmetry 2002, 13, 303.
of the THP-protected organolithium reagent (R)-3 to imine
1 was examined. In both Et2O and THF, the addition
occurred at -78 °C and gave consistently anti-4 as the major
(7) Senanayake, C. H.; Lu, Z.-H.; Li, N. S.; Rubin, P. D.; Jerussi, T. P.
(Sepracor, Inc.). PCT Appl. WO 02/046138 A2, June 13, 2002.
2600
Org. Lett., Vol. 7, No. 13, 2005